15 Feb 2016

Perspective: What will personalised medicine be worth by 2020?

New research indicates that the core personalized medicine market will be worth over $149 billion by 2020 with a compound annual growth rate (CAGR) of 8.74%.

"The total personalised targeted therapeutic market, for all indications, will grow at a CAGR of 6.47% over the next five years. Strong vertical growth in the companion diagnostic segment however will see a CAGR of 23.71% to 2020, mainly coming from oncology, cardiovascular and infectious disease (HIV/HCV) tests. Advancing technologies within the liquid biopsy market is also driving the market and will see strategic growth over the next five years with a CAGR of 20.6%. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies."

Reference
Related Posts Plugin for WordPress, Blogger...